|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross Profit | |||
| OPERATING EXPENSES | |||
| Selling | |||
| General and administrative | |||
| Research and development | |||
| Total operating expenses | |||
| LOSS FROM OPERATIONS | |||
| Other Income (Expense) | |||
| Interest income | |||
| Interest expense | |||
| Amortization of debt discounts | |||
| Other income | |||
| Other expenses | |||
| Impairment loss in goodwill | |||
| Total other income (expense) | |||
| LOSS BEFORE TAXES | |||
| Income tax expense | |||
| NET LOSS | |||
| Other comprehensive income | |||
| Foreign currency translation adjustment | |||
| Total comprehensive loss | |||
| Basic earnings per share | |||
| Diluted earnings per share | |||
| Weighted average number of shares of common stock outstanding – basic | |||
| Weighted average number of shares of common stock outstanding –diluted |
Loading...